This is a very interesting question. imo, we sh
Post# of 148185
(Total Views: 581)
Posted On: 10/20/2020 8:48:25 AM
This is a very interesting question.
imo, we should be using a one-tailed test.
Why??? The two-tailed assumes that the drug could actually be DETRIMENTAL to the patients.
If the only outcome is that the drug will benefit (and only benefit) them one should use a on-tailed test.
This should be the case with Leronlimab pristine safety record.
imo, we should be using a one-tailed test.
Why??? The two-tailed assumes that the drug could actually be DETRIMENTAL to the patients.
If the only outcome is that the drug will benefit (and only benefit) them one should use a on-tailed test.
This should be the case with Leronlimab pristine safety record.
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼